BIOKMIR is developing a point-of-care diagnostic tool to detect multi-drug resistant tuberculosis (MDR-TB) infection. According to the Stop TB Partnership, only one in three people with drug resistant TB are being treated today and an additional 3 million people each year go without any TB diagnosis. Prevention methods and organized treatment strategies exist and are being applied globally, however, the combination of accessibility of personalized diagnostics and spikes in antimicrobial resistance have complicated efforts to eradicate tuberculosis. A point-of-care lab-on-syringe device offers an unparalleled platform for clinical applications.
Leadership
Zakariya Kmir
Robert H. Smith School of Business